The MRC Laboratory of Molecular Biology (LMB) have agreed to an additional $4 million funding to extend the Blue Sky collaboration with AstraZeneca beyond 2022.
The Blue Sky collaboration, launched in 2014, has supported a range of pre-clinical research projects which encourage ‘blue sky’ thinking around fundamental biology and disease.
